cbdMD agreed to acquire certain Twinlab Assets for approximately $1,750,000 ($1.75 million) of assumed Debt and 2,229,805 common shares (2.23 million). The transaction matters to investors because it combines secured debt and stock consideration, while cbdMD’s 591,207 outstanding Series B shares now carry a $0.60 conversion price.
Key Highlights
- The common-stock consideration equals 19.9% of cbdMD’s outstanding shares at agreement execution.
- CbdMD reduced the Series B conversion price from $1.00 to $0.60 per share effective September 2, 2026.
- The acquired assets include Twinlab Subsidiary stock, intellectual property, inventory, receivables, Goodwill and cash.
CbdMD, Inc. (AMEX: YCBD) agreed to acquire certain Twinlab assets for approximately $1,750,000 ($1.75 million) of assumed debt, secured by the acquired assets. It will also issue 2,229,805 common shares (2.23 million) to Akretive Holdings, LLC, subject to leak-out restrictions after closing and potential stockholder approval under NYSE American rules.
Twinlab Assets and Purchase Consideration
The transaction involves cbdMD subsidiary To Be Brands, LLC, Twinlab Consolidated Holdings, Inc. Twinlab subsidiaries, assignee Philip J. Von Kahle and Akretive Holdings. CbdMD will assume the stated debt and other liabilities identified in the agreement.
Series B Conversion Terms Change
The 2,229,805 common shares represent 19.9% of cbdMD’s outstanding common stock when the agreement was executed. If the outstanding share count rises before closing, the stock consideration will increase to reach the 19.99% target, subject to the agreement’s terms. CbdMD also amended its Series B Convertible Preferred Stock designation, changing the conversion price from $1.00 to $0.60 per share effective September 2, 2026. The amendment covers 591,207 issued and outstanding Series B shares, while the designation had authorized 1,700,000 shares of that preferred-stock class.
Peers Moving on This News
- Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) down 6.0%
- Enveric Biosciences, Inc. (NASDAQ: ENVB) up 1.9%



Please wait processing your request...